Q-linea AB (publ) (QLINEA.ST)
SEK 0.97
(-1.62%)
SEK 0.97
(-1.62%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 20.56 Million SEK | -1.74% |
| 2022 | 20.92 Million SEK | 26392.41% |
| 2021 | 79 Thousand SEK | -76.13% |
| 2020 | 331 Thousand SEK | -53.31% |
| 2019 | 709 Thousand SEK | -37.2% |
| 2018 | 1.12 Million SEK | -62.37% |
| 2017 | 3 Million SEK | 0.0% |
| 2016 | - SEK | -100.0% |
| 2015 | 213 Thousand SEK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 56.98 Million SEK | 249.53% |
| 2024 Q1 | 16.3 Million SEK | -20.72% |
| 2023 Q1 | 49.75 Million SEK | 137.73% |
| 2023 FY | 20.56 Million SEK | -1.74% |
| 2023 Q4 | 20.56 Million SEK | -7.89% |
| 2023 Q3 | 22.32 Million SEK | -79.75% |
| 2023 Q2 | 110.24 Million SEK | 121.58% |
| 2022 Q2 | - SEK | -100.0% |
| 2022 Q4 | 20.92 Million SEK | 0.0% |
| 2022 Q1 | 40 Thousand SEK | -49.37% |
| 2022 FY | 20.92 Million SEK | 26392.41% |
| 2022 Q3 | - SEK | 0.0% |
| 2021 Q4 | 79 Thousand SEK | -33.61% |
| 2021 Q2 | 171 Thousand SEK | -32.14% |
| 2021 Q1 | 252 Thousand SEK | -23.87% |
| 2021 FY | 79 Thousand SEK | -76.13% |
| 2021 Q3 | 119 Thousand SEK | -30.41% |
| 2020 Q4 | 331 Thousand SEK | -19.46% |
| 2020 Q3 | 411 Thousand SEK | -17.64% |
| 2020 Q2 | 499 Thousand SEK | -17.38% |
| 2020 Q1 | 604 Thousand SEK | -14.81% |
| 2020 FY | 331 Thousand SEK | -53.31% |
| 2019 Q3 | 814 Thousand SEK | -11.43% |
| 2019 FY | 709 Thousand SEK | -37.2% |
| 2019 Q2 | 919 Thousand SEK | -10.25% |
| 2019 Q4 | 709 Thousand SEK | -12.9% |
| 2019 Q1 | 1.02 Million SEK | -9.3% |
| 2018 Q1 | - SEK | -100.0% |
| 2018 FY | 1.12 Million SEK | -62.37% |
| 2018 Q4 | 1.12 Million SEK | -8.51% |
| 2018 Q3 | 1.23 Million SEK | -90.87% |
| 2018 Q2 | 13.51 Million SEK | 0.0% |
| 2017 Q1 | - SEK | 0.0% |
| 2017 FY | 3 Million SEK | 0.0% |
| 2017 Q4 | 3 Million SEK | 0.0% |
| 2016 FY | - SEK | -100.0% |
| 2015 FY | 213 Thousand SEK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AddLife AB (publ) | 5.28 Billion SEK | 99.611% |
| Biotage AB (publ) | 150 Million SEK | 86.29% |
| Bonesupport Holding AB (publ) | 17.48 Million SEK | -17.622% |
| Doxa AB (publ) | 9.7 Million SEK | -112.01% |
| Elekta AB (publ) | 7.24 Billion SEK | 99.716% |
| iZafe Group AB (publ) | 3.17 Million SEK | -547.717% |
| Ortivus AB (publ) | 5.48 Million SEK | -275.205% |
| Ortivus AB (publ) | 5.48 Million SEK | -275.205% |
| S2Medical AB (publ) | - SEK | -Infinity% |
| Synsam AB (publ) | 3.25 Billion SEK | 99.368% |